Validation and Counseling of Prescriptions for Controlled Substances and Opioids

Pharmacist & Pharmacy Tech CEU
notesMonograph
Contact Hours: 2.0 (0.2 CEUs)

Course Summary

Controlled substances may be prescribed to patients for legitimate medical purposes. However, controlled substances, such as opioids, may be misused. Patients must be assessed for the appropriate therapeutic use of controlled substances so that misuse, addiction, or dependence does not occur. To protect patients from the inappropriate use of controlled substances, clinicians must know the laws and rules related to the prescribing and dispensing of controlled substances. Clinicians in Florida must utilize the prescription drug monitoring program database and incorporate protocols for addressing and resolving problems recognized during a drug utilization review, as required by Florida law. Pharmacists are particularly situated to counsel patients with opioid prescriptions on the proper storage and disposal of controlled substances, standing orders for reversal agents, such as naloxone, and treatment resources for opioid physical dependence, addiction, or misuse.


Course Objectives

Describe the laws and rules related to the prescribing and dispensing of controlled substances, including the Standards of Practice for the Filling of Controlled Substance Prescriptions and Electronic Prescribing in Florida (Fla. Admin. Code, Rule 64B16-27.831)

How to Ensure access to controlled substances for all patients with a valid prescription, including assessment of prescriptions for appropriate therapeutic value, and pharmacist-initiated counseling of patients with opioid prescriptions

Describe the use of the Prescription Drug Monitoring Program’s Database

Identify the risk for controlled substance misuse, addiction, or dependence and detection of prescriptions not based on a legitimate medical purpose

Describe available treatment resources for opioid physical dependence, addiction, misuse, or abuse.

Counsel patients about the proper storage and disposal of controlled substances and the available treatment resources for opioid physical dependence, addiction, or misuse

Describe how to treat an opioid overdose, which includes reversal agents or standing orders for naloxone, including the Florida State Surgeon

General’s Statewide Standing Order for Naloxone Describe protocols for addressing and resolving problems recognized during the drug utilization review, including but not limited to drug/drug interactions, side effects, and high-dose/low-dose guidelines


I. Introduction

II. Controlled Substances Act and Other Regulations

A. Schedules of Controlled Substance
B. Stock Ordering of Controlled Substances
C. Storage, Recordkeeping, and Disposal of Controlled Substances
D. State-Level Scheduling and Regulations
E. Staying Up-to-Date

III. Drug Enforcement Administration (DEA)

IV. Prescription Drug Misuse

V. Prevention of Prescription Drug Misuse

A. Motivational Interviewing (MI) Techniques
B. Ensuring Appropriate Access
C. Legitimate Concerns or “Red Flags”
D. Basic Prescribing Best Practices
E. Basic Dispensing Best Practices
F. Implementation and Use of PDMPs
G. Florida State Prescription Drug Monitoring
H. Drug Diversion and Doctor Shopping

VI. Safe Prescribing of Opioids

A. Indications for Opioid Pain Treatment
B. Special Considerations for Opioid Dispensing

VII. Opioid Use Disorder and Pain Management

VIII. Summary

How to Earn Credit:
To earn credit for this course, participants must:
  1. Read the course objectives and faculty planner disclosure
  2. Read the course material
  3. Complete the post-test with a minimum score of 70% and complete the course evaluation form.
  4. Results are automatically submitted to CPE Monitor

Faculty Planner Disclosure

The following individuals were involved in developing this activity: Steven Malen, PharmD, MBA, and Pamela Sardo, PharmD, BS. Pamela Sardo and Steven Malen have no conflicts of interest or financial relationships regarding the subject matter. There are no financial relationships or commercial or financial support relevant to this activity to report or disclose by RxCe.com or any of the individuals involved in the development of this activity.


Unlabeled Use Disclosures

The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.

Computer Hardware/Software Requirements

Please ensure the device you plan to use meets these requirements and specifications:

  • Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
  • Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
  • A connection to the internet
  • For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.

star star star star star ) ) star )

Rating: 5/5

Based on the ratings of 17 customers

  • Target Audience: Pharmacist, Pharmacy Tech
  • Contact Hours: 2.0 (0.2 CEUs)
  • Activity Release Date: 9/20/2024
  • Activity Expiration Date: 9/20/2025
  • Activity Type: Knowledge
  • UAN: 0669-0000-24-127-H08-P
  • Topic: Pain Management/Opioids
  • CeBroker Number: 20-1247410

Author:

Steve Malen, PharmD, MBA

AUTHOR BIO

VIEW PDF

The logo for the Accreditation Council for Pharmacy Education (ACPE).

RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The logo for the Pharmacy Technician Certification Board (PTCB).
PTCB Course Recognition

RxCe.com, LLC, offers pharmacy technician continuing education courses for PTCB recertification. Pharmacy technician courses are indicated both in the Target Audience description and the ACPE UAN which will end with a "T".

‹‹ Back to Course List